Effect of MK0524A on Flushing Caused by Niacin (0524A-056)
Clinical trial NCT00533611 · COMPLETED
Trial details
- NCT number
- NCT00533611
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2007-08-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.